HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kala Kirby Selected Research

Amyloid beta-Peptides

11/2023Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kala Kirby Research Topics

Disease

7Alzheimer Disease (Alzheimer's Disease)
11/2023 - 11/2023
3Cognitive Dysfunction
11/2023 - 11/2023
2Dementia (Dementias)
11/2023 - 11/2023

Drug/Important Bio-Agent (IBA)

6Amyloid (Amyloid Fibrils)IBA
11/2023 - 11/2023
2Biomarkers (Surrogate Marker)IBA
11/2023 - 11/2023
1Apolipoproteins E (ApoE)IBA
11/2023
14- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA
11/2023
17- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
11/2023
1Amyloid beta-PeptidesIBA
11/2023